Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.

Hulit J, Lee RJ, Li Z, Wang C, Katiyar S, Yang J, Quong AA, Wu K, Albanese C, Russell R, Di Vizio D, Koff A, Thummala S, Zhang H, Harrell J, Sun H, Muller WJ, Inghirami G, Lisanti MP, Pestell RG.

Cancer Res. 2006 Sep 1;66(17):8529-41.

2.

Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.

Hershko DD.

Cancer. 2008 Apr 1;112(7):1415-24. doi: 10.1002/cncr.23317. Review.

3.

p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.

Philipp-Staheli J, Payne SR, Kemp CJ.

Exp Cell Res. 2001 Mar 10;264(1):148-68. Review.

PMID:
11237531
4.

p27(Kip1) signaling: Transcriptional and post-translational regulation.

Hnit SS, Xie C, Yao M, Holst J, Bensoussan A, De Souza P, Li Z, Dong Q.

Int J Biochem Cell Biol. 2015 Nov;68:9-14. doi: 10.1016/j.biocel.2015.08.005. Epub 2015 Aug 14. Review.

PMID:
26279144
5.

Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.

Auerkari EI.

Oral Oncol. 2006 Jan;42(1):5-13. Epub 2005 Jun 22. Review.

PMID:
15978859
6.

Co-opted integrin signaling in ErbB2-induced mammary tumor progression.

Carraway KL 3rd, Sweeney C.

Cancer Cell. 2006 Aug;10(2):93-5. Review.

7.

Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.

Andrechek ER, Muller WJ.

Cell Cycle. 2004 Sep;3(9):1111-3. Epub 2004 Sep 1. Review.

PMID:
15326381
8.

Tumor formation in Brca1 conditional mutant mice.

Deng CX.

Environ Mol Mutagen. 2002;39(2-3):171-7. Review.

PMID:
11921186
9.

Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Musgrove EA, Davison EA, Ormandy CJ.

J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):55-66. Review.

PMID:
15082918
10.

Roles of the Skp2/p27 axis in the progression of chronic nephropathy.

Suzuki S, Ohashi N, Kitagawa M.

Cell Mol Life Sci. 2013 Sep;70(18):3277-87. doi: 10.1007/s00018-012-1232-x. Epub 2012 Dec 20. Review.

11.

The non-canonical functions of p27(Kip1) in normal and tumor biology.

Sharma SS, Pledger WJ.

Cell Cycle. 2016 May 2;15(9):1189-201. doi: 10.1080/15384101.2016.1157238. Epub 2016 Apr 15. Review.

12.

p27Kip1 and human cancers: A reappraisal of a still enigmatic protein.

Bencivenga D, Caldarelli I, Stampone E, Mancini FP, Balestrieri ML, Della Ragione F, Borriello A.

Cancer Lett. 2017 Sep 10;403:354-365. doi: 10.1016/j.canlet.2017.06.031. Epub 2017 Jul 5. Review.

PMID:
28687353
13.

MYC Modulation around the CDK2/p27/SKP2 Axis.

Hydbring P, Castell A, Larsson LG.

Genes (Basel). 2017 Jun 30;8(7). pii: E174. doi: 10.3390/genes8070174. Review.

14.

TGIF function in oncogenic Wnt signaling.

Razzaque MS, Atfi A.

Biochim Biophys Acta. 2016 Apr;1865(2):101-4. doi: 10.1016/j.bbcan.2015.10.003. Epub 2015 Nov 11. Review.

PMID:
26522669
15.

Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.

Lee HS, Kundu J, Kim RN, Shin YK.

Int J Mol Sci. 2015 Dec 15;16(12):29815-28. doi: 10.3390/ijms161226203. Review.

16.

[Mts1 protein and control of tumor metastasis].

Georgiev GP, Lukanidin EM.

Mol Biol (Mosk). 2000 Sep-Oct;34(5):727-30. Review. Russian. No abstract available.

PMID:
11033794
17.

Diverse ways to control p27Kip1 function: miRNAs come into play.

le Sage C, Nagel R, Agami R.

Cell Cycle. 2007 Nov 15;6(22):2742-9. Epub 2007 Aug 16. Review.

PMID:
17986865

Supplemental Content

Support Center